Neurology Central

FENS 2018: Novel treatments for multiple sclerosis on the horizon

Finding ways to help repair the damage caused to nerve cells by multiple sclerosis (MS) is a big ambition for scientists in the research field. At the FENS Forum of Neuroscience (7–11 July, Berlin, Germany), researchers from the USA and UK have come a step closer to identifying new treatments for the disease.
Study number one:

Jonah Chan (University of California, CA, USA) is investigating the use of clemastine fumarate for the treatment of MS. A clinical trial conducted by Chan has demonstrated for the first time, a modest but significant degree of remyelination in patients.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.